| Market Capitalization (Millions $) |
3,663 |
| Shares
Outstanding (Millions) |
41 |
| Employees |
898 |
| Revenues (TTM) (Millions $) |
668 |
| Net Income (TTM) (Millions $) |
154 |
| Cash Flow (TTM) (Millions $) |
79 |
| Capital Exp. (TTM) (Millions $) |
67 |
Business Description
TransMedics Group Inc. (NASDAQ: TMDX) is a medical technology company headquartered in Andover, Massachusetts that is dedicated to improving organ transplant outcomes. The company was founded in 1998 and has since developed innovative solutions to maintain organ viability during transportation, known as the Organ Care System (OCS).
The OCS is a portable platform that enables organ transplants by providing uninterrupted blood flow, oxygenation, and preservation of organs during transportation. The OCS is compatible with a variety of organ types, including hearts, lungs, and livers, and has been shown to increase the number of organs suitable for transplantation and improve transplant outcomes.
TransMedics is focused on increasing patient access to transplants by improving organ preservation and reducing the risk of transplant-related complications. The company is dedicated to delivering innovative tools and services that can significantly increase the number of organs available for transplantation.
The company has a global presence, with a presence in Europe, the United States, and Asia. TransMedics has commercialized the OCS in over 30 countries and has obtained regulatory approval for its products from major regulatory authorities, including the United States, Europe, Canada, and Australia.
TransMedics has also received numerous awards and accolades for its innovative technology, including being named a finalist in the 2021 Edison Best New Product Awards for its OCS LUNG platform.
TransMedics is positioned for continued growth, with a strong pipeline of ongoing clinical trials and a dedicated team of experts working to develop new solutions that are transforming the field of organ transplant medicine. The company is committed to bringing its innovative technologies to organ transplant patients around the world, providing hope and new opportunities for those in need of life-saving transplants.
Company Address: 200 Minuteman Road Andover 1810 MA
Company Phone Number: 552-0900 Stock Exchange / Ticker: NASDAQ TMDX
|
6.14% 
115.36 %